MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells

Baoliang Guo1, Ken Inoki, Motohide Isono

  • 1Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.

Kidney International
|August 18, 2005
PubMed
Abstract

Insights

Transforming growth factor-beta (TGF-beta) induces plasminogen activator inhibitor-1 (PAI-1) expression in rat mesangial cells via the mitogen-activated protein kinase (MAPK)/activator protein-1 (AP-1) pathway. This MAPK/AP-1 requirement is specific to rats, unlike in humans.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta (TGF-beta) signaling regulates gene expression through receptor-regulated Smads and mitogen-activated protein kinases (MAPKs).
  • Plasminogen activator inhibitor-1 (PAI-1) is a key gene regulated by TGF-beta, but its promoter sequence differs between species.
  • Understanding species-specific mechanisms is crucial for TGF-beta research.

Purpose of the Study:

  • To elucidate the mechanisms of TGF-beta-induced PAI-1 expression in rat mesangial cells.
  • To investigate the roles of MAPKs, Smads, and transcription factors in regulating rat PAI-1 gene expression.
  • To compare TGF-beta signaling pathways in rat versus human systems.

Main Methods:

  • Northern blot analysis for PAI-1 and c-fos mRNA.
  • Immunoblot analysis for MAPK and Smad activation.
  • Electrophoretic mobility shift assay (EMSA) for DNA binding.
  • Luciferase reporter assay for promoter activity.

Main Results:

  • TGF-beta1-induced PAI-1 and c-fos expression were dependent on the ERK/JNK-AP-1 pathway, inhibited by MEK inhibitors.
  • An AP-1-like sequence in the rat PAI-1 promoter was essential for basal and TGF-beta1-induced activity.
  • Smad nuclear translocation and binding to SBE occurred independently of MEK inhibition and did not affect PAI-1 promoter activity.
  • Interferon-gamma (IFN-gamma) inhibited TGF-beta1-induced PAI-1 via the ERK-AP-1 pathway.

Conclusions:

  • MAPK/AP-1 activation is essential for TGF-beta1-induced PAI-1 expression in rat mesangial cells.
  • This reliance on MAPK/AP-1 is a unique characteristic of rat PAI-1 regulation.
  • The findings highlight species-specific differences in TGF-beta signaling pathways.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...